Molecular Diagnosis & Therapy

Papers
(The TQCC of Molecular Diagnosis & Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker141
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects92
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review75
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors63
A Window of Opportunity for Newborn Screening61
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate50
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors45
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date44
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”37
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights36
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target36
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma34
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors28
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?28
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk27
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach26
Afamitresgene Autoleucel: First Approval24
Advances and Challenges in the Diagnosis of Leishmaniasis23
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology22
Personalizing Oncolytic Immunovirotherapy Approaches21
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics21
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease20
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges20
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders20
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy19
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”18
Smart PROTACs Enable Controllable Protein Degradation for Precision Cancer Therapy17
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations17
Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review16
Molecular Therapeutics in Development to Treat Alzheimer’s Disease16
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study16
MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review16
The Road Traveled and Journey Ahead for the Genetics and Genomics of Tinnitus15
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy15
Long-Range PCR and Nanopore Sequencing Enables High-Throughput Detection of TCF4 Trinucleotide Repeat Expansions in Fuchs Endothelial Corneal Dystrophy15
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort14
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia14
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis14
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer14
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease13
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants13
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?13
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies13
Achromatopsia: Genetics and Gene Therapy13
Preimplantation Genetic Testing for Monogenic Conditions: Is Cell-Free DNA Testing the Next Step?12
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis12
Lifileucel: First Approval12
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation12
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients12
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings11
Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases11
The Role οf Ion Channels in the Development and Progression of Prostate Cancer11
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders11
Correction to: Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-210
Emerging RNAi Therapies to Treat Hypertension10
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”10
Correction to: Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus10
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer10
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting9
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models9
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R9
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab9
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma9
0.044474840164185